Drug Development and Drug Usage
Syllabus, Bachelor's level, 3FB500
This course has been discontinued.
- Code
- 3FB500
- Education cycle
- First cycle
- Main field(s) of study and in-depth level
- Pharmaceutical Biosciences G1N, Pharmaceutical Chemistry G1N, Pharmacy G1N
- Grading system
- Pass with distinction (VG), Pass (G), Fail (U)
- Finalised by
- The Educational Board of Pharmacy, 25 April 2019
- Responsible department
- Department of Pharmaceutical Biosciences
General provisions
This course substitutes and corresponds to the 3FB300 Drug Development and Drug Usage. 1.5 credits (hp) correspond to 1 credit point (p) according to previous study regulation.
Entry requirements
Accepted to the Master of Science Programme in Pharmacy or Bachelor of Science in Pharmacy Programme
Learning outcomes
The course aims to give the students an insight into drug development and usage by knowing how to - define basic terms and concept within the framework of drug development and usage. - account for the drug structure, effect and the path of drug through the body as well as different forms of administration. - account for toxicity studies and clinical trials. - describe the role of clinics and patients in development and using of drug. - account for the Medical Products Agencys function as authority and the role of pharmacies as supplier of drug and as informants to users. - seek information about drugs in FASS and Läkemedelsboken. - seek information and compile a scientific report and present this both oral and written
Content
The course includes principles for drug development where the structure and effect of drugs, the path through the body, forms of administration and using drug in different situations are included. In the course, problems for an understanding of scientific methodology are also included. Safety aspects on drug as requirements on research documentation, clinical trials and toxicity studies. The role of the clinic and patients in development and using of drug. The function of the Medical Products Agency as the regulatory authority and the role of pharmacies as suppliers of pharmaceutical products and as informants to users. The course is thus intended to give the student an overview of drug development as a basis for further studies and an introduction to the importance of drugs in the treatment of illness.
Instruction
The studies are partly problem-based and expire from lifelike situations and focus on drug and drug-related issues that the students might meet in their future professional role. Basic understanding of the subject is acquired through lectures and problem-based learning (PBL) in tutorial groups with approximately 8 students and a tutor. Other tuition forms are an assignment and computer-basedexercises. Large emphasis is placed on the students own learning, likewise the ability to independently seek information in literature and other sources. The course also provides training in oral and written presentations and to cooperate with other people. Compulsory parts of the course: PBL-meetings, mirror presentations including the introduction, computer-based exercises and written and oral presentation of the assignment.
Assessment
The course ends with a written examination. Supplementation of compulsory parts may be done at the earliest at next course and then only if there is a vacancy.